AQR Strips ‘Risk Parity’ Name From Mutual Fund After Redemptions (Bloomberg)
AQR Capital Management’s flagship risk parity mutual fund, which has suffered big outflows, will no longer be billed as a risk parity fund. The firm, which helped popularize the investing style, is changing the name and tweaking the strategy for its $344 million AQR Risk Parity Fund, according to a November regulatory filing. The rebranded AQR Multi-Asset Fund will have more leeway to bet against stocks and bonds, among other changes, which may help it navigate volatile markets.
$9 Billion Hedge Fund Manager David Abrams, Who Rarely Makes Public Appearances, Lays Out His Investing Strategy – and Cautions Against Being Too Patient (Business Insider)
David Abrams, who manages nearly $9 billion with his fund, Abrams Capital, rarely makes public appearances. He told attendees at a New York conference on Friday that while a short-term-only focus from investors will only end up hurting a company in the long term, managers can actually be too patient. “The long term is made up of a lot short terms,” said Abrams, who is a protégé of Baupost‘s Seth Klarman. He derided investors who look for the easy way out, saying there’s “no algorithm” for investing.
Rawpixel.com/Shutterstock.com
Lampert’s Hedge Fund Makes Bid for Sears Stores and Assets (The Wall Street Journal)
Lampert’s Hedge Fund Makes Bid for Sears Stores and Assets. Edward Lampert, the chairman and biggest creditor of Sears Holdings Corp., has made an offer to buy the retailer’s stores and other assets out of bankruptcy court in a bid to keep control of the struggling chain.
Ray Dalio on the Next Financial Crisis, How He Started his Own Hedge Fund, Transparency at Work, and More (Business Insider)
At IGNITION 2018, Ray Dalio of Bridgewater Associates talked about starting his own hedge fund, recovering from big mistakes, what the next financial crisis will look like, transparency at work, and more.
Insider Buying: Infinity Pharmaceuticals Inc. (INFI) Major Shareholder Acquires 1,465,126 Shares of Stock (FairFieldCurrent.com)
Infinity Pharmaceuticals Inc. (NASDAQ:INFI) major shareholder Bvf Partners L. P/Il acquired 1,465,126 shares of the firm’s stock in a transaction on Monday, November 19th. The stock was bought at an average price of $1.37 per share, with a total value of $2,007,222.62. The transaction was disclosed in a filing with the SEC.
Insider Buying: FuelCell Energy Inc (NASDAQ:FCEL) Director Acquires 100,000 Shares of Stock (MareaInformativa.com)
FuelCell Energy Inc (NASDAQ:FCEL) Director John A. Rolls purchased 100,000 shares of the business’s stock in a transaction that occurred on Tuesday, November 20th. The stock was bought at an average cost of $0.75 per share, with a total value of $75,000.00. Following the acquisition, the director now owns 417,274 shares in the company, valued at approximately $312,955.50. The purchase was disclosed in a legal filing with the Securities & Exchange Commission.
Insider Buying: Athenex Inc (NASDAQ:ATNX) CEO Acquires 40,000 Shares of Stock (MareaInformativa.com)
Athenex Inc (NASDAQ:ATNX) CEO Johnson Yiu Nam Lau acquired 40,000 shares of the firm’s stock in a transaction on Wednesday, November 14th. The stock was acquired at an average cost of $10.47 per share, with a total value of $418,800.00. Following the acquisition, the chief executive officer now owns 2,887,422 shares of the company’s stock, valued at $30,231,308.34. The purchase was disclosed in a document filed with the SEC.
Insider Selling: Amarin Co. plc (AMRN) Insider Sells 607,611 Shares of Stock (FairFieldCurrent.com)
Amarin Co. plc (NASDAQ:AMRN) insider John F. Thero sold 607,611 shares of the firm’s stock in a transaction on Monday, November 12th. The shares were sold at an average price of $19.07, for a total value of $11,587,141.77. The sale was disclosed in a filing with the SEC.
Insider Buying: Summer Infant, Inc. (SUMR) Major Shareholder Buys $30,300.00 in Stock (XNewsPress.com)
Summer Infant, Inc. (NASDAQ:SUMR) major shareholder Wynnefield Partners Small Cap bought 30,000 shares of the stock in a transaction on Monday, December 3rd. The shares were bought at an average cost of $1.01 per share, for a total transaction of $30,300.00. The purchase was disclosed in a legal filing with the SEC.
